-
Women may have another choice in emergency contraception (EC) if a current multi-site trial of a potential candidate proves successful. HRA Pharma of Paris, France, has initiated a pivotal multicenter Phase III study to evaluate its proprietary second-generation emergency contraceptive.
-
About one in four U.S. females between the ages of 14 and 59 may have human papillomavirus (HPV), according to results of the first national estimate of the infection.
-
How many men enter the doors of your family planning clinic, and what services can you offer them outside of free condoms? Consider vasectomy: It is simpler, safer, less expensive, and as effective as the currently available methods of female sterilization, according to Contraceptive Technology.
-
While two advanced trials have been closed for one microbicide candidate for HIV prevention in women, researchers are pressing forward in examining other contenders that may prove safe and effective in the fight against the AIDS epidemic.
-
The National Association of Nurse Practitioners in Women's Health (NPWH) has announced its endorsement of cervical cancer screening guidelines that support the use of HPV (human papillomavirus) testing along with the Pap test for routine screening of women 30 and older.
-
As clinicians begin to integrate use of the first cervical cancer vaccine (Gardasil, Merck & Co., Whitehouse Station, NJ) into their practice, developers of an investigational vaccine have launched a head-to-head study of the two vaccines.
-
AHC Media appreciates the faith you have placed in us to provide you with practical, authoritative information.
-
Students who seek contraceptive services at college and university health centers are facing sticker shock when it comes to picking up their supplies. As a result of changes to the federal Deficit Reduction Act (DRA) that were implemented in January 2007, institutions of higher education no longer qualify for special reduced pricing for contraceptive supplies.
-
The next patient in your examination room is an adolescent female who says she wants the "acne pill." What are your options?
-
Women who are interested in nonhormonal contraception will see wider access to the Today contraceptive sponge now that a new company is in charge of its marketing and distribution.
